Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 8 studies | 34% ± 12% | |
| basal cell | 7 studies | 30% ± 12% | |
| dendritic cell | 7 studies | 47% ± 13% | |
| pancreatic ductal cell | 3 studies | 57% ± 23% | |
| enterocyte | 3 studies | 21% ± 2% | |
| transit amplifying cell | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 95% | 3493.83 | 313 / 328 | 93% | 205.04 | 166 / 178 |
| stomach | 72% | 3464.66 | 258 / 359 | 98% | 172.76 | 279 / 286 |
| intestine | 42% | 3627.78 | 401 / 966 | 97% | 201.08 | 513 / 527 |
| esophagus | 39% | 13531.84 | 559 / 1445 | 99% | 262.25 | 181 / 183 |
| bladder | 38% | 2206.43 | 8 / 21 | 95% | 200.97 | 480 / 504 |
| prostate | 47% | 1491.19 | 116 / 245 | 84% | 38.07 | 422 / 502 |
| lung | 30% | 861.33 | 175 / 578 | 94% | 139.42 | 1087 / 1155 |
| kidney | 92% | 3637.67 | 82 / 89 | 11% | 7.83 | 102 / 901 |
| ureter | 0% | 0 | 0 / 0 | 100% | 218.04 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 242.75 | 44 / 45 |
| uterus | 2% | 278.21 | 3 / 170 | 85% | 201.84 | 388 / 459 |
| liver | 32% | 702.73 | 72 / 226 | 52% | 65.79 | 213 / 406 |
| skin | 72% | 16688.04 | 1299 / 1809 | 12% | 11.57 | 56 / 472 |
| ovary | 0% | 0 | 0 / 180 | 83% | 49.73 | 358 / 430 |
| breast | 11% | 261.75 | 49 / 459 | 57% | 43.63 | 640 / 1118 |
| thymus | 0% | 2.64 | 1 / 653 | 54% | 27.05 | 324 / 605 |
| heart | 7% | 295.14 | 59 / 861 | 0% | 0 | 0 / 0 |
| muscle | 3% | 79.91 | 25 / 803 | 0% | 0 | 0 / 0 |
| adipose | 0% | 23.81 | 6 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 20.40 | 4 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 8.25 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0005604 | Cellular component | basement membrane |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0005198 | Molecular function | structural molecule activity |
| Gene name | LAD1 |
| Protein name | Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA) Ladinin 1 Ladinin-1 (Lad-1) |
| Synonyms | LAD |
| Description | FUNCTION: Anchoring filament protein which is a component of the basement membrane zone. . FUNCTION: Anchoring filament protein which is a component of the basement membrane zone. . FUNCTION: Anchoring filament protein which is a component of the basement membrane zone. . |
| Accessions | E9PDI4 O00515 ENST00000632743.1 ENST00000631576.1 Q6IPJ9 ENST00000391967.7 ENST00000367313.4 A0A0J9YVY2 ENST00000633953.1 A0A0J9YW63 A0A0J9YYF6 |
